Sarit Assouline, Biljana Culjkovic-Kraljacic, Julie Bergeron, Stephen Caplan, Eftihia Cocolakis, Caroline Lambert, Cara J. Lau, Hiba Ahmad Zahreddine, Wilson H. Miller, Katherine L. B. Borden. A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E. haematol [Internet]. 2014Dec.31 [cited 2024Apr.28];100(1):e7-e9. Available from: https://haematologica.org/article/view/7269